Why the study?
Thirty per cent of patients presenting with proximal femoral fractures receive anticoagulants, which may require reversal prior to surgery, causing surgical delay.
How should anticoagulant and antiplatelet therapy be managed in patients presenting with proximal femoral fractures requiring surgery?
Population
Patients presenting with proximal femoral fractures who are receiving anticoagulant treatment
Design
Review
Authors
Loading...
May support continuing platelet inhibitors without delay in hip fracture surgery; hypothesis-generating and requires higher-level confirmation.
How should anticoagulant and antiplatelet therapy be managed in patients presenting with proximal femoral fractures requiring surgery?
This review outlines practical strategies for managing various anticoagulants in patients requiring urgent hip fracture surgery to balance bleeding risks and surgical delays.
Papachristos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: